Clinical Trials
2 trialsNCT01130519 2025-02-21
A Phase II Study of Bevacizumab and Erlotinib in Subjects With Advanced Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC) or Sporadic Papillary Renal Cell Cancer
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT00971620 2017-04-07
Randomized Pilot Study for the Treatment of Cutaneous Leiomyomas With Botulinum Toxin
National Institutes of Health Clinical Center (CC)
Phase 2 Completed